这家医药CDMO企业CEO离职! ADC赛道的战略抉择

中国制药网
Oct 16

2025 年 10 月13日,东曜药业一则高管变动公告引发 医药行业 关注:公司执行董事、首席执行官、首席科学官刘军和非执行董事、副董事长黄纯莹由于个人原因辞任。与此同时,资本方代表、维梧资本管理合伙人付山由非执行董事调任执行董事,全面主导公司管理与发展。业内表示,这场管理层更迭,不仅是企业治理结构的调整,更折射出 生物医药 行业在创新与资本博弈中的战略转向。公开资料显示,刘军今年58岁,辞任前...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10